The focus of this work is to highlight the most recent advances in the understanding of cleft lip and palate occurrence. Information regarding research on long-term outcomes, genes and their interactions with other genes, and gene-environment interactions is compiled to provide the reader with a critical and up-to-date overview on the current knowledge of the etiology of cleft lip and palate. Recent epidemiological evidence strongly suggests that individuals born with clefts have a shorter lifespan and may have a higher incidence of cancer and psychological disorders. IRF6 has been shown to be an important contributor to cleft lip and palate, but the functional variant leading to the defect has not yet been defined. Inactivation of MSX1 and genes in the FGF family has also been shown to lead to cleft lip and palate. In addition, missense mutations in several candidate genes may cause cleft lip and palate, but definitive evidence regarding the biological consequences of these mutations is yet to be unraveled. Maternal cigarette smoking increases the risk of a baby born with clefts, in particular when the mother carries the GSTT1-null variants. The latest approaches in cleft research include the analysis of several additional phenotypical features of the population, with the goal of increasing the statistical power of genetics studies.
Get full access to this article
View all access options for this article.
References
1.
Avila JR, Jezewski PA, Vieira AR, Orioli IM, Castilla EE, Christensen K, et al. -2006-. PVRL1 variants contribute to non-syndromic cleft lip and palate in multiple populations. Am J Med Genet A140:2562–2570.
2.
Bille C, Winther JF, Bautz A, Murray JC, Olsen J, Christensen K -2005-. Cancer risk in persons with oral cleft—a population-based study of 8,093 cases. Am J Epidemiol161:1047–1055.
3.
Blin-Wakkach C, Lezot F, Ghoul-Mazgar S, Hotton D, Monteiro S, Teillaud C, et al. -2001-. Endogenous Msx1 antisense transcript: in vivo and in vitro evidences, structure, and potential involvement in skeleton development in mammals. Proc Natl Acad Sci USA98:7336–7341.
4.
Chakravarti A -2004-. Finding needles in haystacks—IRF6 gene variants in isolated cleft lip or cleft palate. N Engl J Med351:822–824.
5.
Chishti MS, Muhammad D, Haider M, Ahmad W -2006-. A novel missense mutation in MSX1 underlies autosomal recessive oligodontia with associated dental anomalies in Pakistani families. J Hum Genet51:872–878.
6.
Christensen K, Mortensen PB -2002-. Facial clefting and psychiatric diseases: a follow-up of the Danish 1936–1987 Facial Cleft cohort. Cleft Palate Craniofac J39:392–396.
7.
Christensen K, Juel K, Herskind AM, Murray JC -2004-. Long term follow up of survival associated with cleft lip and palate birth. BMJ328:1405.
8.
De Muynck S, Schollen E, Matthijs G, Verdonck A, Devriendt K, Carels C -2004-. A novel MSX1 mutation in hypodontia. Am J Med Genet A128:401–403.
9.
Fogh-Andersen P -1942-. Inheritance of harelip and cleft palate. Copenhagen: Munksgaard.
10.
Frebourg T, Oliveira C, Hochain P, Karam R, Manouvrier S, Graziadio C, et al. -2006-. Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer. J Med Genet43:138–142.
11.
Gaspar DA, Matioli SR, de Cássia Pavanello R, Araújo BC, Alonso N, Wyszynski D, et al. -2004-. Maternal MTHFR interacts with offspring’s BCL3 genotypes, but not with TGFA, in increasing risk to nonsyndromic cleft lip with or without cleft palate. Eur J Hum Genet12:521–526.
12.
Honein MA, Rasmussen SA, Reefhuis J, Romitti PA, Lammer EJ, Sun L, et al. -2007-. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology18:226–233.
13.
Jezewski PA, Vieira AR, Nishimura C, Ludwig B, Johnson M, O’Brien SE, et al. -2003-. Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. J Med Genet40:399–407.
14.
Jugessur A, Wilcox AJ, Lie RT, Murray JC, Taylor JA, Sangstad OD, et al. -2003-. Variants of developmental genes -TGFA, TGFB3, and MSX1- and their associations with orofacial clefts: a case-parent triad analysis. Genet Epidemiol24:230–239.
15.
Jumlongras D, Bei M, Stimson JM, Wang WF, DePalma SR, Seidman CE, et al. -2001-. A nonsense mutation in MSX1 causes Witkop syndrome. Am J Hum Genet69:67–74.
16.
Katsanis N, Ansley SJ, Badano JL, Eichers ER, Lewis RA, Hoskins BE, et al. -2001-. Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science293:2256–2259.
17.
Kim JW, Simmer JP, Lin BP, Hu JC -2006-. Novel MSX1 frameshift causes autosomal-dominant oligodontia. J Dent Res85:267–271.
18.
Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y, et al. -2002-. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet32:285–289.
19.
Lammer EJ, Shaw GM, Iovannisci DM, Finnell RH -2004-. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 -NAT1-, and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol70:846–852.
20.
Letra A, Menezes R, Granjeiro JM, Vieira AR -2007-. Defining subphenotypes for oral clefts based on dental development. J Dent Res86:986–991.
21.
Lidral AC, Reising BC -2002-. The role of MSX1 in human tooth agenesis. J Dent Res81:274–278.
22.
Lidral AC, Romitti PA, Basart AM, Doetschman T, Leysens NJ, Daack-Hirsch S, et al. -1998-. Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet63:557–568.
23.
Mansilla MA, Cooper ME, Goldstein T, Castilla EE, Lopez-Camelo JS, Marazita ML, et al. -2006-. Contributions of PTCH gene variants to isolated cleft lip and palate. Cleft Palate Craniofac J43:21–29.
24.
Marçano ACB, Doudney K, Braybrook C, Squires R, Patton MA, Lees MM, et al. -2004-. TBX22 mutations are a frequent cause of cleft palate. J Med Genet41:68–74.
25.
Marcucio RS, Cordero DR, Hu D, Helms JA -2005-. Molecular interactions coordinating the development of the forebrain and face. Dev Biol284:48–61.
26.
Modesto A, Moreno LM, Krahn K, King S, Lidral AC -2006-. MSX1 and orofacial clefting with and without tooth agenesis. J Dent Res85:542–546.
27.
Mossey PA, Little J -2002-. Epidemiology of oral clefts: an international perspective. In: Cleft lip & palate. From origin to treatment. Wyszynski DF, editor. New York: Oxford University Press, pp. 127–158.
28.
Neiswanger K, Weinberg SM, Rogers CR, Brandon CA, Cooper ME, Bardi KM, et al. -2007-. Orbicularis oris muscle defects as an expanded phenotypic feature in nonsyndromic cleft lip with or without cleft palate. Am J Med Genet A143:1143–1149.
29.
Nopoulos P, Langbehn DR, Canady J, Magnotta V, Richman L -2007-. Abnormal brain structure in children with isolated clefts of the lip or palate. Arch Pediatr Adolesc Med161:753–758.
30.
Ogawa T, Kapadia H, Wang B, D’Souza RN -2005-. Studies of Pax9-Msx1 protein interactions. Arch Oral Biol50:141–145.
31.
Ogawa T, Kapadia H, Feng JQ, Raghow R, Peters H, D’Souza RN -2006-. Functional consequences of interactions between Pax9 and Msx1 genes in normal and abnormal tooth development. J Biol Chem281:18363–18369.
32.
Riley BM, Mansilla MA, Ma J, Daack-Hirsch S, Maher BS, Raffensperger LM, et al. -2007-. Impaired FGF signaling contributes to cleft lip and palate. Proc Natl Acad Sci USA104:4512–4517.
33.
Schliekelman P, Slatkin M -2002-. Multiplex relative risk and estimation of the number of loci underlying an inherited disease. Am J Hum Genet71:1369–1385.
34.
Shi M, Christensen K, Weinberg CR, Romitti P, Bathum L, Lozada A, et al. -2007a-. Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants. Am J Hum Genet80:76–90.
35.
Shi M, Umbach DM, Weinberg CR -2007b-. Identification of risk-related haplotypes with the use of multiple SNPs from nuclear families. Am J Hum Genet81:53–66.
36.
Suzuki Y, Jezewski PA, Machida J, Watanabe Y, Shi M, Cooper ME, et al. -2004-. In a Vietnamese population, MSX1 variants contribute to cleft lip and palate. Genet Med6:117–125.
37.
Tongkobpetch S, Siriwan P, Shotelersuk V -2006-. MSX1 mutations contribute to nonsyndromic cleft lip in a Thai population. J Hum Genet51:671–676.
38.
van den Boogard MJ, Dorland M, Beemer FA, van Amstel HK -2000-. MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet24:342–343.
39.
Vastardis H, Karimbux N, Guthua SW, Seidman JG, Seidman CE -1996-. A human MSX1 homeodomain missense mutation causes selective tooth agenesis. Nat Genet13:417–421.
40.
Vieira AR, Orioli IM, Castilla EE, Cooper ME, Marazita ML, Murray JC -2003-. MSX1 and TGFB3 contribute to clefting in South America. J Dent Res82:289–292.
41.
Vieira AR, Castillo TS, Aravena T, Astete C, Sanz P, Tastets ME, et al. -2004a-. Mutational analysis of the muscle segment homeobox gene -MSX1- in Chilean patients with cleft lip/palate. Rev Med Chil132:816–822.
42.
Vieira AR, Meira R, Modesto A, Murray JC -2004b-. MSX1, PAX9, and TGFA contribute to tooth agenesis in humans. J Dent Res83:723–727.
43.
Vieira AR, Avila JR, Daack-Hirsch S, Dragan E, Félix TM, Rahimov F, et al. -2005-. Medical sequencing of candidate genes for nonsyndromic cleft lip and palate. PLoS Genet1:e64.
44.
Vieira AR, Modesto A, Meira R, Barbosa ARS, Lidral AC, Murray JC -2007a-. Interferon regulatory factor 6 -IRF6- and fibroblast growth factor receptor 1 -FGFR1- contribute to human tooth agenesis. Am J Med Genet A143:538–545.
45.
Vieira AR, Cooper ME, Marazita ML, Orioli IM, Castilla EE -2007b-. Interferon regulatory factor 6 -IRF6- is associated with oral-facial cleft in individuals that originate in South America. Am J Med Genet A143:2075–2078.
46.
Warrington A, Vieira AR, Christensen K, Orioli IM, Castilla EE, Romitti PA, et al. -2006-. Genetic evidence for the role of loci at 19q13 in cleft lip and palate. J Med Genet43:e26.
47.
Watanabe A, Akita S, Tin NT, Natsume N, Nakano Y, Niikawa N, et al. -2006-. A mutation in RYK is a genetic factor for nonsyndromic cleft lip and palate. Cleft Palate Craniofac J43:310–316.
48.
Wilcox AJ, Lie RT, Solvoll K, Taylor J, McConnaughey DR, Abyholm F, et al. -2007-. Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ334:464.
49.
Zeiger JS, Beaty TH, Liang KY -2005-. Oral clefts, maternal smoking, and TGFA: a meta-analysis of gene-environment interaction. Cleft Palate Craniofac J42:58–63.
50.
Zhu JL, Basso O, Hasle H, Winther JF, Olsen JH, Olsen J -2002-. Do parents of children with congenital malformations have a higher cancer risk? A nationwide study in Denmark. Br J Cancer87:524–528.
51.
Zucchero TM, Cooper ME, Maher BS, Daack-Hirsch S, Nepomuceno B, Ribeiro L, et al. -2004-. Interferon regulatory factor 6 -IRF6- gene variants and the risk of isolated cleft lip and palate. N Engl J Med351:769–780.
